Home › Glioblastoma › Virginia
Pag-aaral pangklinika para sa Glioblastoma sa Virginia
10 pag-aaral para sa Glioblastoma ang naghahanap ng mga kalahok sa mga site sa Virginia.
Mga Lungsod sa Virginia
Opisyal na teksto ng pag-aaral (English)
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- Inova Schar Cancer Institute, Fairfax
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07195591A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- University of Virginia Health, Charlottesville
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT03970447Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Inova Schar Cancer Institute, Fairfax
- VCU Massey Comprehensive Cancer Center, Richmond
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07326566VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma
- Inova Schar Cancer, Fairfax
Nagre-recruitPhase 2
Edad 18 hanggang 98 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07831369FearLess in NeuroOncology
- Virginia Commonwealth University, Richmond
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06989086SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- UVA Health, Emily Couric Clinical Cancer Cente, Charlottesville
- Inova Schar Cancer Institute, Fairfax
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05303519Study of Low-Intensity Focused Ultrasound in Combination With Immunotherapy in Newly Diagnosed Unmethylated Glioblastoma
- University of Virginia, Charlottesville
Nagre-recruitPhase 1
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update May 6, 2026 · NCT07343986Sonodynamic Therapy in Patients With Recurrent GBM
- University of Virginia, Charlottesville
Nagre-recruitPhase 1
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Abr 28, 2026 · NCT06039709Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- NEXT Virginia, Fairfax
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT06810544SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Charlottesville
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.